Follow Us

Log in


  • November 22, 2019 5:09 PM | Anonymous

    The New York Workers’ Compensation Board Drug Formulary (NY WC Formulary) becomes effective on December 5, 2019.

    All new prescriptions for injured workers in New York State must be listed within the NY WC Formulary unless an alternative medication has been approved through the NYS Workers’ Compensation Board’s new prior authorization process.

    The new electronic prior authorization process will soon be available through the Board’s Medical Portal; please watch for the notification.

    Please visit the Board’s Drug Formulary Overview webpage for:

    • An overview of the NY WC Formulary and the prior authorization process
    • The latest version of the NY WC Formulary (effective 11/5/19)
    • A video overview for Medical Providers
    • A Quick Guide to the NY WC Formulary
    • An NY WC Formulary Dashboard Guide for Medical Providers

    Information and resources related to requesting prior authorization through the Board’s Medical Portal, can be found on the Board’s Medical Portal Overview webpage.

    For more information or assistance:

  • November 20, 2019 3:46 PM | Anonymous

    The NY Chapter of the ACS has worked with MSSNY and numerous physician advocacy groups in support of multiple pieces of legislation to reduce physicians’ administrative burden to ensure that their patients can receive the medications they need. Recent successes  include a law that gives physicians greater authority to override a health insurer “step therapy” or “fail first” prescription medication protocol in certain circumstances. 

    However, there is still work to do to  reduce the need for unnecessary and repetitive prior authorizations that take time away from your patient care delivery.  During its annual advocacy day event, the NY Chapter advocated in support for prior authorization reform > read more

    MSSNY has developed a survey to obtain data regarding the extent of your  prior authorization hassles.

    We encourage you to take part in this survey and to help us educate the legislature on the necessity for reform!  Complete the survey

  • November 19, 2019 2:40 PM | Anonymous

    On Tuesday, November 19th, State Attorney General Letitia James announced a lawsuit aimed at JUUL Labs.  In it, the company is accused of using deceptive and misleading marketing in the sale of its e-cigarettes. The suit alleges the practice contributed to the youth vaping epidemic in New York.

    According to James’ office, JUUL illegally sold its products to minors though its website and third-party retail stores throughout the state resulting in  a large number of young people to become addicted to nicotine. In addition, the suit alleges the company misrepresented its products as a safer alternative to traditional cigarettes.

    “There can be no doubt that JUUL’s aggressive advertising has significantly contributed to the public health crisis that has left youth in New York and across the country addicted to its products,” James said in a statement. “By glamorizing vaping, while at the same time downplaying the nicotine found in vaping products, JUUL is putting countless New Yorkers at risk.”

    The New York State Department of Health says there have been 42 deaths and 2,172 cases of severe vaping-related illnesses across the country, including 146 cases in New York.

    The New York Chapter ACS strongly recommends that every effort be made to prevent the initiation of e-cigarettes by youth and adults. The use of products containing nicotine in any form is unsafe and in youth can harm brain development. Furthermore, evidence indicates that young e-cigarette users are at increased risk for both starting to smoke and becoming long-term users of combustible tobacco products. > Read our statement on e-Cigarette, Cannabis and Tobacco Use

  • November 17, 2019 3:38 PM | Anonymous

    The American College of Surgeons Young Fellows Association (ACS YFA) Communications Committee is developing a series of short, animated videos to explain how to establish and maintain an online presence as a surgeon.

    The first video, available on the ACS website, discusses the three types of websites: canned databases, personal websites, and professional society profiles. Watch the first video in the series and make sure to check back soon as more are added.

  • November 15, 2019 3:41 PM | Anonymous

    The NY Chapter of the ACS encourages interested surgeons and associate members to apply for ACS Fellowship before the December 1 deadline. If you are eligible to become a Fellow, applications received by December 1 will be considered for conferral of Fellowship at the 2020 Clinical Congress, October 4–8, in Chicago, IL. 

     The letters FACS (Fellow, American College of Surgeons) after a surgeon’s name mean that the surgeon’s education and training, professional qualifications, surgical competence, and ethical conduct have passed a rigorous evaluation, and have been found to be consistent with the high standards established and demanded by the College. Take this opportunity to become a Fellow and add this important designation to your credentials.  

     In addition to the many benefits outlined in the FACS brochure, Fellows of the ACS have the opportunity to engage with other surgeons in their community by joining one of the College’s 114 local chapters. At the chapter level, surgeons can network and build strong relationships with surgical peers, participate in advocacy and educational activities, take on leadership roles, give back to the profession through volunteerism, and mentor young surgeons.

    Visit the Become a Fellow webpage and realize the potential of your profession today!
  • November 08, 2019 10:55 AM | Anonymous

    The U.S. House of Representatives October 28 passed the Palliative Care and Hospice Education and Training Act (PCHETA), H.R. 647/S. 2080.

    A priority of the 2019 ACS Advocacy Summit and At Home Program, the bill would improve the training of health professionals in palliative care by creating Palliative Care and Hospice Education Centers to provide short-term, intensive courses focused on palliative care and establishing traineeships for individuals preparing for advanced degrees as nurses, social workers, or physician assistants who focus their studies in palliative care. In addition, the legislation expands palliative care research to strengthen clinical practice and improve care delivery for patients with serious or life-threatening illnesses.

    H.R. 647/S. 2080 was introduced by Reps. Eliot Engel (D-NY), Tom Reed (R-NY), Yvette Clarke (D-NY), Buddy Carter (R-GA), Frank Pallone (D-NJ), and Greg Walden (R-OR) and Sens. Tammy Baldwin (D-WI) and Shelley Moore Capito (R-WV). The American College of Surgeons (ACS) will continue its advocacy on this important issue to ensure swift passage of the bill in the U.S. Senate.

    For more information about PCHETA, contact Amelia Suermann, ACS Congressional Lobbyist, at

  • November 07, 2019 10:58 AM | Anonymous

    The NYS Workers Compensation Board Drug Formulary (NY WC Formulary) becomes effective in four weeks (12/5/19) for new prescriptions.

    Training materials related to the NY WC Formulary, as well as an updated version of the NY WC Formulary (effective 11/5/19), can be found on the NYS Workers Compensation webpage:

    Drug Formulary OverviewSystem pages

    Information and resources related to the Board's Medical Portal, which is used to access the prior authorization system, can be found on our Medical Portal Overview webpage.

    For more information or assistance


    General Formulary questions: email

    Technical Support questions: email

    Subscribe for email notifications at

  • October 14, 2019 11:00 AM | Anonymous

    The CDC has penned a new name for vaping-related illness: EVALI, which stands for e-cigarette, or vaping, product use associated lung injury, according to new healthcare recommendations the agency released Oct. 11.  

    The interim guidelines focus on initial assessment, criteria for hospital admission and treatment, patient follow-up, considerations for high-risk groups and public recommendations regarding EVALI. Rapid diagnosis and an understanding of treatment options could reduce EVALI morbidity and mortality, the CDC said. 

    Initial assessment recommendations include a respiratory virus panel, especially during flu season, and evaluation of community-acquired pneumonia. Treatment guidelines suggest using corticosteroids. Of 140 patients who received the medication nationwide, 82 percent showed improvement, according to the CDC. However, the agency cautions providers to withhold corticosteroids when evaluating for infectious etiologies, like pneumonia, that could potentially worsen with corticosteroid treatment.  

    CDC is currently developing guidelines for EVALI healthcare encounters as new data emerges. While the exact chemicals responsible for the illness are still unknown, CDC recommends people stop or decrease use of products containing THC and/or nicotine.  

    As of November 5, 2019, 2,051* cases of e-cigarette, or vaping, product use associated lung injury (EVALI) have been reported to CDC from 49 states (all except Alaska), the District of Columbia, and 1 U.S. territory.

    • Thirty nine deaths in 24 states and the District of Columbia: Alabama, California (3), Connecticut, Delaware, District of Columbia, Florida, Georgia (3), Illinois (3), Indiana (3), Kansas (2), Massachusetts (2), Michigan, Minnesota (3), Mississippi, Missouri, Montana, Nebraska, New Jersey, New York, Oregon (2), Pennsylvania, Tennessee (2), Texas, Utah, and Virginia.
      • The median age of deceased patients was 53 years and ranged from 17 to 75 years (as of November 5, 2019).

    For EVALI updates from the CDC, click here.

  • October 11, 2019 11:11 AM | Anonymous

    Applications are due Friday, November 15

    The International Relations Committee of the American College of Surgeons (ACS) has announced the availability of traveling fellowships to Australia and New Zealand (ANZ), Germany, and Japan.

     The traveling fellowships encourage the international exchange of information concerning surgical science, practice, and education and foster professional and academic collaborations and friendships.  The traveling fellowships, which are available in most surgical specialties, are open to ACS Fellows under the age of 50.

     The Traveling Fellows will spend a minimum of two or three weeks in the countries that they visit. Their activities will include attending and participating in the 2020 annual scientific meeting of the host country: Royal Australasian College of Surgeons, Perth (May 3-7); Germany Society of Surgery, Munich (April 8–10); and Japan Surgical Society, Chiba (April 8–10). View the full description and a link to the application form on the ACS website. [].

    Questions may be directed to the Scholarships Administrator, at

  • October 07, 2019 11:25 AM | Anonymous

    The closing date for receipt of applications and all supporting documents is November 15, 2019

    The College offers faculty research fellowships through the generosity of Fellows, Chapters, and friends of the College, to surgeons entering academic careers in surgery or a surgical specialty.  These fellowships assist surgeons in the establishment of a new and independent research program.  Applicants should have demonstrated their potential to work as independent investigators.  The fellowship award is $40,000 per year to support the research.

     The Franklin Martin Fellowship honors the College's founder.  The C. James Carrico Fellowship is dedicated to trauma and critical care research.  There are two more undesignated fellowships. All of them are two years in length. 

     The full requirements and application form are posted on the ACS website at   Questions may be directed to the Scholarships Administrator, at

About us

Uniting efforts to improve the quality of surgical practice in NYS and care to surgical patients.

Become a member

Elevate your career and join your local Chapter today!

Contact us

New York Chapter American College of Surgeons
150 State Street, Floor 4, Albany NY 12207  Phone: (518) 953-5401 |  Fax: (518) 514-1424

Powered by Wild Apricot Membership Software